Doxofylline: a "novofylline"

Overview

Journal Pulm Pharmacol Ther

Specialty Pulmonary Medicine

Date 2010 Apr 13

PMID 20380886

Citations 15

Authors

Clive P Page

Affiliations

Soon will be listed here.

Abstract

Xanthines such as theophylline have been used in the treatment of lung diseases since the early 1900's, but have a major drawback of a very narrow therapeutic window and many drug/drug interactions. With the increasing availability of other classes of drugs, this has limited the use of xanthines. Doxofylline is a xanthine molecule that appears to be both bronchodilator and anti-inflammatory with an improved therapeutic window over conventional xanthines such as theophylline and the evidence supporting the effects of doxofylline in the treatment of lung diseases is discussed.

Citing Articles

Doxophylline With Paroxysmal Supraventricular Tachycardia: A Case Report.

Yu D, Liu M, Tang W Clin Med Insights Case Rep. 2024; 17:11795476241266395.

PMID: 39282243 PMC: 11402082. DOI: 10.1177/11795476241266395.

Assessment of Bitterness in Non-Charged Pharmaceuticals with a Taste Sensor: A Study on Substances with Xanthine Scaffold and Allopurinol.

Zhao Z, Song F, Kimura S, Onodera T, Uchida T, Toko K Molecules. 2024; 29(11).

PMID: 38893328 PMC: 11173402. DOI: 10.3390/molecules29112452.

A narrative review of theophylline: is there still a place for an old friend?.

Scurek M, Brat K J Thorac Dis. 2024; 16(5):3450-3460.

PMID: 38883616 PMC: 11170423. DOI: 10.21037/jtd-23-1781.

Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl-tRNA synthetase 1.

Yoon I, Kim S, Cho M, You K, Son J, Lee C EMBO Mol Med. 2023; 15(7):e16940.

PMID: 37212275 PMC: 10331583. DOI: 10.15252/emmm.202216940.

Studying the Mechanism of Interaction of Doxofylline with Human Lysozyme: A Biophysical and In Silico Approach.

Alomar S Molecules. 2023; 28(8).

PMID: 37110695 PMC: 10146846. DOI: 10.3390/molecules28083462.